Description
Composition
Active substance:
Prostate Extract – 100 mg in terms of soluble peptides – 20 mg ;.
Excipients:
Hard fat (Witepsol, brand H 15, W 35; supposir, grade NA 15, NAS 50) – a sufficient amount to obtain a suppository weighing 1.25 g
Description:
Suppositories are torpedo-shaped white to yellowish, Valium or a grayish color. It allowed the appearance of white deposits on the surface of the suppository and the presence of air at the exit of the rod and the funnel-shaped recess.
Product form:
20 mg rectal suppositories. 5 suppositories in blisters of PVC film laminated with polyethylene. Two blisters with instruction for medical use the drug in a pile of cardboard.
Contraindications
Increased sensitivity to the drug.
Indications
Chronic prostatitis (in the complex therapy). Benign prostatic hyperplasia. Treatment of urgent (imperative) urinary incontinence, urgent (imperative) urge to urinate and frequent urination in uncomplicated forms of overactive bladder in women in menopause and postmenopausal periods. The state before and after surgical interventions on the prostate gland.
Interaction with other drugs
The drug can be used in combination therapy. Cases interaction or incompatibility described with other drugs.
Overdose
No cases of overdose were reported Vitaprost® Forte.
pharmachologic effect
Pharmacological group:
Treatment for chronic prostatitis
Pharmacological properties:
Vitaprost® Forte has Organotropona action on the prostate. Reduces the degree of swelling, leukocytic infiltration prostate, normalizes the secretory function of epithelial cells, increases the number of lecithin granules secret acini, stimulates the muscle tone of the bladder. Improves microcirculation in the prostate by reducing thrombus formation, antiplatelet activity, prevents the development of thrombosis in the prostate gland venules.
Based on clinical trial data demonstrated that Vitaprost® Forte moderately reduces the volume of the prostate gland. The drug reduces the severity of obstructive and irritative symptoms of benign prostatic hyperplasia, which results in increasing the maximum and average volumetric flow rates of urine and decrease residual urine volume.
Vitaprost® Forte improves blood circulation in the bladder wall by expanding the intact vessels (vasodilation effect), this helps to restore oxygen delivery to the tissues experiencing hypoxia that stimulates physiological reparation. Anti-inflammatory effect by improving the trophism of the bladder wall processes and stimulation of regenerative processes.
Activation of organ blood flow and improves the adaptation of detrusor contractile activity, increasing the bladder capacity.
Ischemia detrusor decrease can be explained by a marked reduction of bladder hyperactivity, which continues after the end of application Vitaprost® Forte.
Vitaprost® Forte helps normalize prostate parameters and ejaculate. It reduces pain and discomfort, eliminates dysuria, improves the copulatory function.
Pharmacodynamics:
Vitaprost® Forte has Organotropona action on the prostate. Reduces the degree of swelling, leukocytic infiltration prostate, normalizes the secretory function of epithelial cells, increases the number of lecithin granules secret acini, stimulates the muscle tone of the bladder. Improves microcirculation in the prostate by reducing thrombus formation, antiplatelet activity, prevents the development of thrombosis in the prostate gland venules. Vitaprost® Forte normalizes parameters of prostate and semen. It reduces pain and discomfort, eliminates dysuria, improves the copulatory function. The drug has anti-inflammatory and antiaggregation effect, stimulating the muscles of the bladder. The active substances of prostate extract belong to the group of peptide bioregulators – cytomedines. These drugs are peptides with a molecular weight of from 1 to 10 kDa. Low molecular weight peptides para- or autocrine nature, function as transspetsifichnyh intra- and intercellular messenger. The peptides of the prostate decreased clotting time and increased vascular wall antiaggregation activity, improve blood circulation, reinforce the fibrinolytic activity of blood, increase the contractile activity of the detrusor muscle cells in vivo, in vitro. Have immunomodulatory and immunostimulatory activity, enhance the synthesis of antihistamine and antiserotonin antibodies. The use of peptide-based bioregulators in the treatment of chronic prostatitis is the ability of these agents to restore microcirculation to provide indirect anti-inflammatory action by enhancing the synthesis of antihistamine and antiserotonin antibodies and their immunomodulatory and immunostimulatory effects. Treatment of benign prostatic hyperplasia based on important biological effect cytomedines: Organotropona to regulate the differentiation and function of cells in the body from which they were allocated.
Pharmacokinetics:
As the peptide drug is cleaved by cellular proteases to amino acids. Cumulative effect is not.
Conditions of supply of pharmacies
Without recipe.
side effects
Often – 1-10%; sometimes – 0.1-1%; rarely – 0.01-0.1%; very rarely – less than 0.01%, including some cases. Very rare – allergic reactions. If any of the above side effects are compounded or you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
Treatment of chronic prostatitis must be integrated, along with the assignment presupposes preparation Vitaprost® Forte use of other groups of drugs and non-drug therapies. Prior to the treatment of chronic prostatitis and, if necessary, in the course of treatment is recommended to carry out the analysis of prostate secretion. During the period of preparation for the treatment of benign prostatic hyperplasia should regularly visit the doctor for routine control of the disease. Before you begin treatment, you must ensure that the pathology is benign.
Use of the drug has no effect on ability to drive and engage in other potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
At temperatures above 25 ° C. Keep out of the reach of children.
Dosing and Administration
Rectally. 1 suppository after spontaneous bowel cleansing enema or 1 per day. After introduction of desirable patient staying in bed for 30-40 minutes. The duration of treatment determined by the attending physician. The minimum duration of the course of treatment Vitaprost® Forte in benign prostatic hyperplasia – 15 days in chronic prostatitis – 10 days, with overactive bladder – 20 days. If necessary, may repeat courses. If after treatment there is no improvement or symptoms are aggravated, or there are new symptoms, you should consult with your doctor.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist
There are no reviews yet.